RT Journal Article
SR Electronic
T1 A novel whole-blood stimulation assay to detect and quantify memory T-cells in COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.11.21253202
DO 10.1101/2021.03.11.21253202
A1 William Mouton
A1 Christelle Compagnon
A1 Kahina Saker
A1 Soizic Daniel
A1 Xavier Lacoux
A1 Bruno Pozzetto
A1 Guy Oriol
A1 Sophia Djebali
A1 Franck Berthier
A1 Jacqueline Marvel
A1 Thierry Walzer
A1 Karen Brengel-Pesce
A1 Sophie Trouiller-Assant
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/03/12/2021.03.11.21253202.abstract
AB SARS-CoV-2 specific T-cells responses are essential for virus clearance. We present a novel and simple whole-blood assay allowing the detection of interferon-gamma-producing antiviral T-cells following peptide stimulation. We show that unlike neutralizing antibodies, antiviral memory T-cells persist at least 6 months in convalescent Covid-19 individuals.Competing Interest StatementWM, CC, SD, XL, GO, FB and KBP, are employed in bioMerieux SA, an in vitro diagnostic company.Clinical TrialNCT04341142Funding StatementThis work was supported by bioMerieux SA which provided kits for this study. This research is being supported by Hospices Civils de Lyon and by Fondation des Hospices Civils de Lyon.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite de Protection des Personnes Sud Mediterranee, ID-RCB-2020-A00932-37 ClinicalTrial.gov NCT04341142All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to commercial restrictions